DENDRON-02: Efficacy and Safety of Combined Dendritic Cell Vaccine CaTeVac Immunotherapy and Standard Chemotherapy in Patients with CNS Glial Tumors. First Results. Voprosy onkologii, v. 72, n. 2, p. OF-2504, 8 May2026.